• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006.

作者信息

Dubois-Arber F, Balthasar H, Huissoud T, Zobel F, Arnaud S, Samitca S, Jeannin A, Schnoz D, Gervasoni J P

机构信息

Institute of Social and Preventive Medicine (IUMSP), University Hospital Centre and University of Lausanne, Switzerland.

出版信息

Euro Surveill. 2008 May 22;13(21):18881. doi: 10.2807/ese.13.21.18881-en.

DOI:10.2807/ese.13.21.18881-en
PMID:18761964
Abstract

As a part of the HIV behavioural surveillance system in Switzerland, repeated cross-sectional surveys were conducted in 1993, 1994, 1996, 2000 and 2006 among attenders of all low threshold facilities (LTFs) with needle exchange programmes and/or supervised drug consumption rooms for injection or inhalation in Switzerland. Data were collected in each LTF over five consecutive days, using a questionnaire that was partly completed by an interviewer and partly self administered. The questionnaire was structured around three topics: socio-demographic characteristics, drug consumption, health and risk/preventive behaviour. Analysis was restricted to attenders who had injected drugs during their lifetime (IDUs). Between 1993 and 2006, the median age of IDUs rose by 10 years. IDUs are severely marginalised and their social situation has improved little. The borrowing of used injection equipment (syringe or needle already used by other person) in the last six months decreased (16.5% in 1993, 8.9% in 2006) but stayed stable at around 10% over the past three surveys. Other risk behaviour, such as sharing spoons, cotton or water, was reported more frequently, although also showed a decreasing trend. The reported prevalence of HIV remained fairly stable at around 10% between 1993 and 2006; reported levels of hepatitis C virus (HCV) prevalence were high (56.4% in 2006). In conclusion, the overall decrease in the practice of injection has reduced the potential for transmission of infections. However as HCV prevalence is high this is of particular concern, as the current behaviour of IDUs indicates a potential for further spreading of the infection. Another noteworthy trend is the significant decrease in condom use in the case of paid sex.

摘要

相似文献

1
Trends in drug consumption and risk of transmission of HIV and hepatitis C virus among injecting drug users in Switzerland, 1993-2006.
Euro Surveill. 2008 May 22;13(21):18881. doi: 10.2807/ese.13.21.18881-en.
2
Health trends among drug users attending needle exchange programmes in Switzerland (1994-2000).
AIDS Care. 2006 May;18(4):371-5. doi: 10.1080/09540120500429018.
3
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.HIV 感染者和风险、预防、以及注射吸毒者的检测行为——全国 HIV 行为监测系统,2009 年,美国 20 个城市。
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.
4
Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.HIV感染暴发期间注射吸毒者中丙型肝炎病毒感染的发生率。
CMAJ. 2001 Oct 2;165(7):889-95.
5
Risk factors for hepatitis C virus infection among injecting drug users in Sydney.悉尼注射吸毒者中丙型肝炎病毒感染的风险因素。
Genitourin Med. 1994 Oct;70(5):321-4. doi: 10.1136/sti.70.5.321.
6
Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.冲突环境下丙型肝炎和艾滋病毒的发病率以及减少伤害项目的使用情况:阿富汗喀布尔注射吸毒者的一项观察性队列研究
Harm Reduct J. 2015 Oct 16;12:22. doi: 10.1186/s12954-015-0056-z.
7
Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.印度旁遮普邦西北边境地区注射吸毒者中令人担忧的人类免疫缺陷病毒和丙型肝炎病毒流行情况:患病率及相关因素
Int J STD AIDS. 2014 Jul;25(8):596-606. doi: 10.1177/0956462413515659. Epub 2013 Dec 18.
8
Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.1994 - 2004年西雅图18至30岁注射吸毒者中乙肝病毒、丙肝病毒及人类免疫缺陷病毒的流行趋势、危险行为及预防措施
J Urban Health. 2007 May;84(3):436-54. doi: 10.1007/s11524-007-9178-2.
9
Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.注射吸毒者中丙型肝炎病毒的感染情况:对1995 - 2004年澳大利亚针头和注射器项目参与者全国重复横断面调查的队列分析
J Urban Health. 2009 Jan;86(1):106-18. doi: 10.1007/s11524-008-9330-7. Epub 2008 Nov 1.
10
High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.波兰注射吸毒者中艾滋病毒、丙型肝炎病毒及注射风险的高度地区差异:横断面生物行为研究与基于病例监测的比较
BMC Infect Dis. 2015 Feb 21;15:83. doi: 10.1186/s12879-015-0828-9.

引用本文的文献

1
Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.瑞士伯尔尼州慢性丙型肝炎的微观消除建模:尽管受到 COVID-19 大流行的影响,但仍达到瑞士肝炎防治策略的目标。
PLoS One. 2022 Aug 12;17(8):e0272518. doi: 10.1371/journal.pone.0272518. eCollection 2022.
2
Injection Drug Use Trajectories among Migrant Populations: A Narrative Review.流动人群中的注射吸毒轨迹:一项叙述性综述
Subst Use Misuse. 2018 Jul 29;53(9):1558-1570. doi: 10.1080/10826084.2017.1416404. Epub 2018 Jan 24.
3
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.
针具交换计划和阿片类药物替代疗法预防注射吸毒者丙型肝炎传播
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2.
4
Post-war prevention: Emerging frameworks to prevent drug use after the War on Drugs.战后预防:毒品战争后的新兴框架预防药物滥用。
Int J Drug Policy. 2018 Jan;51:160-164. doi: 10.1016/j.drugpo.2017.06.012. Epub 2017 Jul 19.
5
The North American opioid epidemic: current challenges and a call for treatment as prevention.北美阿片类药物流行:当前挑战及呼吁将治疗作为预防手段
Harm Reduct J. 2017 May 12;14(1):7. doi: 10.1186/s12954-017-0135-4.
6
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland.瑞士丙型肝炎病毒健康与经济负担建模
PLoS One. 2015 Jun 24;10(6):e0125214. doi: 10.1371/journal.pone.0125214. eCollection 2015.
7
Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.阿片类药物维持治疗患者中HIV感染率的种族和性别差异——病例登记分析
Harm Reduct J. 2014 Aug 18;11:23. doi: 10.1186/1477-7517-11-23.
8
The association between social marginalisation and the injecting of alcohol amongst IDUs in Budapest, Hungary.匈牙利布达佩斯 IDUs 中社会边缘化与注射饮酒之间的关联。
Int J Drug Policy. 2011 Sep;22(5):393-7. doi: 10.1016/j.drugpo.2011.05.001. Epub 2011 Jul 20.
9
Health problems among detainees in Switzerland: a study using the ICPC-2 classification.瑞士被拘留者的健康问题:使用国际疾病分类-10 临床修订版第二版进行的研究。
BMC Public Health. 2011 Apr 19;11:245. doi: 10.1186/1471-2458-11-245.